ASHWAGANDHA WARNING: Liver Failure Link & Your Brand

ASHWAGANDHA WARNING: What does the fatal liver failure link mean for your supplement brand? This video dives deep into recent cases of liver injury associated with Ashwagandha, specifically focusing on cholestatic or mixed injury patterns. We'll explore how regulatory bodies, particularly in the UK, view supplements as foods and the implications for medicinal claims.

Discover the scrutiny retailers apply, the need for stronger substantiation, and how to reassess risk statements for restricted ingredients. Learn about mandatory labeling, declaring active ingredients, and the importance of evidence-backed claims to ensure your dietary supplements meet compliance standards. Avoid aggressive claims and understand why retailer acceptance doesn't always equal full compliance. This is crucial for selling supplements safely and effectively.

Nutri.Markets analyzes 25+ countries - regulations, retailers, competitors, and market opportunities in minutes: https://nutri.markets

Disclaimer: This content is for educational purposes only and not legal advice.

Chapters:
00:00 Hook
00:11 Liver Injury Cases Reviewed
00:21 Cholestatic or Mixed Injury
00:31 UK: Supplements as Foods
00:39 No Medicinal Claims
00:47 UK Market: $2.8 Billion
00:56 5.2% CAGR Growth
01:06 Retailer Scrutiny
01:15 Stronger Substantiation
01:24 Reassess Risk Statements
01:33 Restricted Ingredients
01:41 Mandatory Labeling
01:49 Declare Active Ingredients
01:57 Evidence-Backed Claims
02:04 Avoid Aggressive Claims
02:12 Don't Omit Mandatory Info
02:20 Retailer Acceptance ≠ Compliance
02:28 Cta